126 related articles for article (PubMed ID: 17124734)
1. siRNAs meet their match.
Potash J
Nat Methods; 2006 Nov; 3(11):876. PubMed ID: 17124734
[TBL] [Abstract][Full Text] [Related]
2. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis.
Ding H; Schwarz DS; Keene A; Affar el B; Fenton L; Xia X; Shi Y; Zamore PD; Xu Z
Aging Cell; 2003 Aug; 2(4):209-17. PubMed ID: 12934714
[TBL] [Abstract][Full Text] [Related]
3. RNA interference protects against ALS in mouse model.
Burton A
Lancet Neurol; 2005 May; 4(5):274-5. PubMed ID: 15861555
[No Abstract] [Full Text] [Related]
4. An RNAi strategy for treatment of amyotrophic lateral sclerosis caused by mutant Cu,Zn superoxide dismutase.
Xia XG; Zhou H; Zhou S; Yu Y; Wu R; Xu Z
J Neurochem; 2005 Jan; 92(2):362-7. PubMed ID: 15663483
[TBL] [Abstract][Full Text] [Related]
5. Amyotrophic lateral sclerosis and gene therapy.
Miller TM; Smith RA; Cleveland DW
Nat Clin Pract Neurol; 2006 Sep; 2(9):462-3. PubMed ID: 16932606
[No Abstract] [Full Text] [Related]
6. Design of functional small interfering RNAs targeting amyotrophic lateral sclerosis-associated mutant alleles.
Geng CM; Ding HL
Chin Med J (Engl); 2011 Jan; 124(1):106-10. PubMed ID: 21362317
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression.
Wang H; Ghosh A; Baigude H; Yang CS; Qiu L; Xia X; Zhou H; Rana TM; Xu Z
J Biol Chem; 2008 Jun; 283(23):15845-52. PubMed ID: 18367449
[TBL] [Abstract][Full Text] [Related]
8. RNA interference and amyotrophic lateral sclerosis.
Rizvanov AA; Gulluoglu S; Yalvaç ME; Palotás A; Islamov RR
Curr Drug Metab; 2011 Sep; 12(7):679-83. PubMed ID: 21740381
[TBL] [Abstract][Full Text] [Related]
9. siRNA-based inhibition specific for mutant SOD1 with single nucleotide alternation in familial ALS, compared with ribozyme and DNA enzyme.
Yokota T; Miyagishi M; Hino T; Matsumura R; Tasinato A; Urushitani M; Rao RV; Takahashi R; Bredesen DE; Taira K; Mizusawa H
Biochem Biophys Res Commun; 2004 Jan; 314(1):283-91. PubMed ID: 14715277
[TBL] [Abstract][Full Text] [Related]
10. Increase of disease duration of amyotrophic lateral sclerosis in a mouse model by transgenic small interfering RNA.
Yokota T; Sasaguri H; Saito Y; Yamada H; Unno T; Yamamoto Y; Kubodera T; Anzai M; Mitani T; Mizusawa H
Arch Neurol; 2007 Jan; 64(1):145-6. PubMed ID: 17210827
[No Abstract] [Full Text] [Related]
11. RNAi therapy: dominant disease gene gets silenced.
Xu Z; Xia XG
Gene Ther; 2005 Aug; 12(15):1159-60. PubMed ID: 15858609
[No Abstract] [Full Text] [Related]
12. [Gene therapy of ALS with RNA interference].
Yokota T
Rinsho Shinkeigaku; 2009 Nov; 49(11):821-3. PubMed ID: 20030220
[TBL] [Abstract][Full Text] [Related]
13. Identification of a new missense point mutation in exon 4 of the Cu/Zn superoxide dismutase (SOD-1) gene in a family with amyotrophic lateral sclerosis.
Elshafey A; Lanyon WG; Connor JM
Hum Mol Genet; 1994 Feb; 3(2):363-4. PubMed ID: 8004110
[No Abstract] [Full Text] [Related]
14. Familial amyotrophic lateral sclerosis with a point mutation (G37R) of the superoxide dismutase 1 gene: a clinicopathological study.
Inoue K; Fujimura H; Ogawa Y; Satoh T; Shimada K; Sakoda S
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Dec; 3(4):244-7. PubMed ID: 12710516
[TBL] [Abstract][Full Text] [Related]
15. Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis.
Miller TM; Kaspar BK; Kops GJ; Yamanaka K; Christian LJ; Gage FH; Cleveland DW
Ann Neurol; 2005 May; 57(5):773-6. PubMed ID: 15852369
[TBL] [Abstract][Full Text] [Related]
16. [Superoxide dismutase-1 (SOD-1) gene mutation-dependent mechanisms of neural degeneration in amyotrophic lateral sclerosis].
Iłzecka J
Neurol Neurochir Pol; 2001; 35(3):461-9. PubMed ID: 11732268
[TBL] [Abstract][Full Text] [Related]
17. Genotype-phenotype correlation in familial amyotrophic lateral sclerosis with SOD1 mutation.
Alimonti D; Malaspina A; Poloni TE; Ceroni M
Funct Neurol; 2000; 15(3):177-91. PubMed ID: 11062847
[No Abstract] [Full Text] [Related]
18. Founder effect hypothesis of D11Y SOD1 mutation in Italian amyotrophic lateral sclerosis patients.
Lattante S; Marangi G; Luigetti M; Conte A; Mandrioli J; Del Grande A; Zollino M; Sabatelli M
Amyotroph Lateral Scler; 2012 Feb; 13(2):241-2. PubMed ID: 22292847
[No Abstract] [Full Text] [Related]
19. [Autosomal dominant ALS].
Abe K
Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):320-2. PubMed ID: 10434663
[No Abstract] [Full Text] [Related]
20. Identification of two novel mutations and a new polymorphism in the gene for Cu/Zn superoxide dismutase in patients with amyotrophic lateral sclerosis.
Esteban J; Rosen DR; Bowling AC; Sapp P; McKenna-Yasek D; O'Regan JP; Beal MF; Horvitz HR; Brown RH
Hum Mol Genet; 1994 Jun; 3(6):997-8. PubMed ID: 7951252
[No Abstract] [Full Text] [Related]
[Next] [New Search]
